ELEVATION ONCOLOGY INC's ticker is ELEV and the CUSIP is 28623U101. A total of 41 filers reported holding ELEVATION ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,662,760 | -58.8% | 615,837 | -21.7% | 0.00% | -57.1% |
Q1 2024 | $4,035,176 | +3990.3% | 786,584 | +428.3% | 0.01% | – |
Q3 2023 | $98,653 | -37.4% | 148,887 | +43.7% | 0.00% | -100.0% |
Q2 2023 | $157,518 | -80.9% | 103,630 | -76.1% | 0.00% | -91.7% |
Q1 2023 | $825,451 | – | 434,448 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Qiming U.S. Ventures Management, LLC | 2,370,142 | $1,570,456 | 2.08% |
Aisling Capital Management LP | 2,834,910 | $1,878,411 | 0.77% |
venBio Partners LLC | 2,914,255 | $1,930,985 | 0.55% |
TANG CAPITAL MANAGEMENT LLC | 4,000,000 | $2,650,400 | 0.37% |
Velan Capital Investment Management LP | 497,299 | $329,510 | 0.27% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $596,340 | 0.11% |
DAFNA Capital Management LLC | 450,000 | $298,170 | 0.09% |
Ikarian Capital, LLC | 1,171,939 | $776,527 | 0.09% |
CAXTON CORP | 21,813 | $14,453 | 0.06% |
BVF INC/IL | 2,312,200 | $1,532,064 | 0.04% |